Dora Lucia Vallejo Ardila
Dora Lucía Vallejo-Ardila, MBBS., is an international PhD research fellow in surgical oncology and tumour immunology at the Department of Surgery of The University of Melbourne in Australia. She graduated in medicine and general surgery from the Industrial University of Santander in Colombia. She has gained considerable international academic experience working in high profile research environments such as Icahn School of Medicine at Mount Sinai - New York City, USA; Hospital de Clínicas de Porto Alegre, Brazil; University Hospital of Freiburg, Germany; University Hospital of Essen, Germany.
The work of my PhD thesis demonstrates that one of the mechanisms by which Renin-angiotensin inhibitors (RASi) decrease tumour viability and impair metastatic growth. (RASi) is an effective strategy for the restoration of the anti-tumour immune response within the tumour microenvironment of colorectal liver metastases, specifically performing spatial phenotypic characterization of conventional and unconventional T-cells and the expression of inducible immune proteasome subunits. Her work has been published in scientific journals, including Journal of Immunotherapy of Cancer, Oncotarget, PLOSone and Revista Colombiana de Cardiología. Also, she has been awarded: Young Investigator Award, World Symposium Research on Lysosomal Diseases (2017), Runner up Best of the Best Poster at the Australasia Gastrointestinal Trial Group scientific meeting (2019); Runner up Best Poster at the Austin Research Festival by the Austin Medical Research Foundation (2019), Advance Clinical Trial design Scholarship (2019) and nominated for the Olivia Newton-John Cancer Research scholarship (2020).
Dr Vallejo-Ardila is sponsored by the Department of Science, Technology, and Innovation (COLCIENCIAS-Colombia) (Ph. D overseas 679 programs) and the University of Melbourne, Faculty of Medicine, Dentistry and Health Sciences (Postgraduate Research Scholarship 2018-2021).
Abstracts this author is presenting: